Dimensional Fund Advisors LP Has $144.89 Million Stake in Relx Plc (NYSE:RELX)

Dimensional Fund Advisors LP boosted its position in shares of Relx Plc (NYSE:RELX - Free Report) by 4.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,189,886 shares of the technology company's stock after acquiring an additional 121,831 shares during the period. Dimensional Fund Advisors LP owned 0.17% of Relx worth $144,885,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of RELX. Arrowstreet Capital Limited Partnership lifted its position in shares of Relx by 50.3% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,968,739 shares of the technology company's stock worth $89,420,000 after purchasing an additional 658,655 shares during the last quarter. Envestnet Asset Management Inc. increased its position in Relx by 2.6% during the fourth quarter. Envestnet Asset Management Inc. now owns 1,898,927 shares of the technology company's stock worth $86,249,000 after acquiring an additional 48,336 shares during the period. Natixis Advisors LLC raised its stake in Relx by 2.8% during the 4th quarter. Natixis Advisors LLC now owns 1,202,592 shares of the technology company's stock valued at $54,622,000 after purchasing an additional 32,739 shares during the last quarter. Raymond James Financial Inc. bought a new stake in Relx in the 4th quarter valued at $44,516,000. Finally, Bank of Montreal Can grew its position in Relx by 290.3% in the 4th quarter. Bank of Montreal Can now owns 886,758 shares of the technology company's stock worth $40,277,000 after purchasing an additional 659,547 shares during the last quarter. 15.02% of the stock is currently owned by institutional investors.

Relx Price Performance

RELX stock traded up $0.83 during trading on Wednesday, hitting $54.62. The company had a trading volume of 1,087,941 shares, compared to its average volume of 709,121. Relx Plc has a fifty-two week low of $40.77 and a fifty-two week high of $54.80. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. The company has a fifty day moving average price of $49.77 and a two-hundred day moving average price of $48.37. The company has a market cap of $101.09 billion, a P/E ratio of 29.37, a P/E/G ratio of 2.73 and a beta of 0.84.

Relx Increases Dividend

The company also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Friday, May 9th will be given a $0.5586 dividend. The ex-dividend date is Friday, May 9th. This is a positive change from Relx's previous semi-annual dividend of $0.23. This represents a yield of 1.6%. Relx's payout ratio is 59.68%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on RELX shares. Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. StockNews.com lowered Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. The Goldman Sachs Group assumed coverage on Relx in a research note on Wednesday, March 26th. They issued a "buy" rating for the company. Redburn Atlantic began coverage on shares of Relx in a research note on Wednesday, January 8th. They set a "buy" rating on the stock. Finally, Morgan Stanley restated an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Buy".

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.